Hybrinomics Life Science and Diagnostics LLP
About Hybrinomics Life Science and Diagnostics LLP
Data last updated:
Hybrinomics Life Science and Diagnostics LLP is a limited liability partnership (LLP) based in Bangalore, Karnataka, India. It operates in the diagnostic centers and pathology labs segment of the healthcare sector. It was incorporated on 25 January 2017 and has been in existence for over 9 years.
The LLP is registered with the Registrar of Companies (ROC), Bangalore, under LLPIN AAI-3738.
The LLP has a total obligation of contribution of ₹50,000. It is led by designated partners Ardhanari Swamy Meganathan and Prabhu Meganathan.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Site 50 Katha No 974/1 Bilishivale(Village) Bidharahalli (Hobli), Bangalore, Karnataka, India – 560077.
As per the financials filed for FY 2023, the LLP reported a revenue of ₹1.19 Cr, a decline of 67% compared to the previous year. For the same year it recorded a net profit of ₹3.02 Lakh (net margin 2.5%) and EBITDA of ₹22.43 Lakh (EBITDA margin 18.9%). Revenue has grown at a compounded annual rate (CAGR) of 2% over three years and 79% over five years.
Company details
Contact details
Hybrinomics Life Science and Diagnostics LLP's registered office is in Bangalore, Karnataka. Its e-mail address is in the company report.
- Email
- Registered AddressSite 50 Katha No 974/1 Bilishivale(Village) Bidharahalli (Hobli), Bangalore, Karnataka, India – 560077
- IndustryHealthcare, Diagnostic Centers & Pathology Labs
To see the full contact details of Hybrinomics Life Science and Diagnostics LLP, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Hybrinomics Life Science and Diagnostics LLP
FY 2025 filings availableHybrinomics Life Science and Diagnostics LLP reported revenue of ₹1.19 Cr (down 67% YoY) for FY 2023.
Compounded Annual Growth Rate (CAGR)
Revenue fell 67% in the latest year, but over five years it has grown at a compounded annual rate (CAGR) of 79%. EBITDA fell 48% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Income and Expenditure | |||||
| Turnover | |||||
| Other Income | |||||
| Total Income | |||||
| Purchases and Direct Costs | |||||
| Personnel Expenses | |||||
| Administrative Expenses | |||||
| Interest | |||||
| Depreciation | |||||
| Total Expenses | |||||
| Profit Before Tax | |||||
| Tax | |||||
| Profit After Tax | ₹3.02 Lakh | ||||
| Profit Transferred to Partners | |||||
| Assets and Liabilities | |||||
| Partners' Contribution | |||||
| Reserves and Surplus | |||||
| Secured Loans | |||||
| Unsecured Loans | |||||
| Trade Payables | |||||
| Other Liabilities and Provisions | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Loans and Advances | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Statement of Account and Solvency | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 | FY 2018-19 |
|---|---|---|---|---|---|
| Profitability | |||||
| Net Profit Margin | 2.5% | ||||
| Return on Partners' Funds | |||||
| Return on Assets | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Debt to Partners' Funds | |||||
| Interest Coverage | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Turnover Growth | |||||
| Profit Growth | |||||
To see the full financial statements and ratios of Hybrinomics Life Science and Diagnostics LLP, buy the company report.
Designated partners of Hybrinomics Life Science and Diagnostics LLP
Hybrinomics Life Science and Diagnostics has 2 designated partners on record. No former designated partners are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Ardhanari Swamy Meganathan | Designated Partner | 25 Jan 2017 | 9 Years 9 Months | Current |
| Prabhu Meganathan | Designated Partner | 25 Jan 2017 | 9 Years 9 Months | Current |
Legal cases
No court or tribunal cases involving Hybrinomics Life Science and Diagnostics LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Hybrinomics Life Science and Diagnostics LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Hybrinomics Life Science and Diagnostics LLP; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Hybrinomics Life Science and Diagnostics LLP has 2 designated partner changes on record since 2017: 2 appointments. The latest: Ardhanari Swamy Meganathan was appointed as Designated Partner on 25 Jan 2017.
Frequently asked questions
Hybrinomics Life Science and Diagnostics is an active limited liability partnership based in Bangalore, Karnataka, India. The LLP works in diagnostic centers and pathology labs, within the healthcare industry. It was incorporated on 25 January 2017 (9+ years old) and is registered under LLPIN AAI-3738.
Hybrinomics Life Science and Diagnostics has 2 current designated partners:
- Ardhanari Swamy Meganathan - Designated Partner
- Prabhu Meganathan - Designated Partner
The latest financial statements of Hybrinomics Life Science and Diagnostics on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2017 are in the company report.
The LLPIN (Limited Liability Partnership Identification Number) of Hybrinomics Life Science and Diagnostics is AAI-3738. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Hybrinomics Life Science and Diagnostics was incorporated on 25 January 2017, making it 9+ years old. It is registered with the Registrar of Companies, Bangalore.
Ardhanari Swamy Meganathan was appointed as Designated Partner on 25 Jan 2017. Prabhu Meganathan was appointed as Designated Partner on 25 Jan 2017.
The registered office of Hybrinomics Life Science and Diagnostics is at Site 50 Katha No 9741 BilishivaleVillage Bidharahalli Hobli, Bangalore, Karnataka, India – 560077.
Hybrinomics Life Science and Diagnostics operates in the healthcare industry, in the diagnostic centers and pathology labs segment.
Hybrinomics Life Science and Diagnostics can be reached at its registered office: Site 50 Katha No 9741 BilishivaleVillage Bidharahalli Hobli, Bangalore, Karnataka, India – 560077.
Hybrinomics Life Science and Diagnostics is registered under the jurisdiction of the Registrar of Companies (ROC), Bangalore.
Sample company reports
The same report you get when you buy one: financials, directors, ownership, deals, charges, legal cases, brands and filings, with the Excel workbook alongside.
